RLMD Competitors & Alternatives

Compare Relmada Therapeutics Inc with similar stocks in the same industry

Biotechnology

RLMD

Main Stock
$6.41
Tradestie Score
55
Market Cap
$71.69M
Analyst Upside
+97.6%

Top Competitors

234 stocks in Biotechnology
Company Price Market Cap P/E Score Action
TYRA Tyra Biosciences, Inc. Common Stock
$31.94
$715.25M - 61 Compare
DAWN Day One Biopharmaceuticals, Inc. Common Stock
$21.53
$704.73M - 59 Compare
ANL ANL
$10.77
$703.23M - 56 Compare
PVLA Palvella Therapeutics, Inc. Common Stock
$145.70
$699.30M - 57 Compare
GYRE Gyre Therapeutics, Inc. Common Stock
$7.01
$688.47M - 59 Compare
TERN Terns Pharmaceuticals, Inc. Common Stock
$52.95
$683.46M - 57 Compare
ARVN Arvinas, Inc
$8.59
$670.30M - 55 Compare
MGTX MeiraGTx Holdings plc Ordinary Shares
$14.66
$665.30M - 66 Compare
ERAS Erasca, Inc. Common Stock
$18.36
$626.91M - 51 Compare
SVRA Savara Inc.
$6.21
$611.84M - 55 Compare

Data updated: Jul 07, 2026 | Industry: Biotechnology (SIC 2834)

234 stocks in this industry